Funded by AccuNovo Biotechnologies Inc. and the NIH: STTR: Theranostic NTSR1-targeting Agents for Complementary Management of PSMA-negative Prostate Cancer The UNC team will work with Accunovo Biotech, Inc. to evaluate the newly developed agents in NTSR1 positive PC3 animal models. Specifically, UNC will perform 64Cu radiolabeling of NTSR1 targeted compounds that are developed by Accunovo … Continued

Congratulations to Eric Smith, the BRIC Director of Radiopharmacy, for being named a 2020 APhA Fellow by the American Pharmacists Association! The award recognizes member with outstanding professional achievements and service to the field of pharmacy. Dr. Smith is recognized by the association as a leader in nuclear pharmacy practice and for building bridges among … Continued

Researchers led by Zibo Li, PhD, said their findings could make it possible to attach radioactive tags to compounds that previously have been difficult or even impossible to label.